AB Science SA-Product Pipeline Review-2015

AB Science SA-Product Pipeline Review-2015

  • Products Id :- GMDHC07477CDB
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

AB Science SA-Product Pipeline Review-2015


Global Markets Direct's, 'AB Science SA-Product Pipeline Review-2015', provides an overview of the AB Science SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AB Science SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of AB Science SA including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of AB Science SA's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the AB Science SA's pipeline products

Reasons To Buy

Evaluate AB Science SA's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of AB Science SA in its therapy areas of focus

Identify new drug targets and therapeutic classes in the AB Science SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of AB Science SA and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of AB Science SA

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of AB Science SA and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

AB Science SA Snapshot 5

AB Science SA Overview 5

Key Information 5

Key Facts 5

AB Science SA-Research and Development Overview 6

Key Therapeutic Areas 6

AB Science SA-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

AB Science SA-Pipeline Products Glance 11

AB Science SA-Late Stage Pipeline Products 11

Filing rejected/Withdrawn Products/Combination Treatment Modalities 11

Phase III Products/Combination Treatment Modalities 12

AB Science SA-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

AB Science SA-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

AB Science SA-Drug Profiles 16

masitinib 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

AB-8779 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecule to Antagonize KIT816 for Aggressive Mastocytosis, Seminoma and AML 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

AB Science SA-Pipeline Analysis 23

AB Science SA-Pipeline Products by Target 23

AB Science SA-Pipeline Products by Route of Administration 24

AB Science SA-Pipeline Products by Molecule Type 25

AB Science SA-Pipeline Products by Mechanism of Action 26

AB Science SA-Recent Pipeline Updates 27

AB Science SA-Dormant Projects 34

AB Science SA-Discontinued Pipeline Products 35

Discontinued Pipeline Product Profiles 35

masitinib 35

AB Science SA-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Appendix 37

Methodology 37

Coverage 37

Secondary Research 37

Primary Research 37

Expert Panel Validation 37

Contact Us 37

Disclaimer 38

List of Tables

AB Science SA, Key Information 5

AB Science SA, Key Facts 5

AB Science SA-Pipeline by Indication, 2015 7

AB Science SA-Pipeline by Stage of Development, 2015 9

AB Science SA-Monotherapy Products in Pipeline, 2015 10

AB Science SA-Filing rejected/Withdrawn, 2015 11

AB Science SA-Phase III, 2015 12

AB Science SA-Phase II, 2015 13

AB Science SA-Preclinical, 2015 14

AB Science SA-Discovery, 2015 15

AB Science SA-Pipeline by Target, 2015 23

AB Science SA-Pipeline by Route of Administration, 2015 24

AB Science SA-Pipeline by Molecule Type, 2015 25

AB Science SA-Pipeline Products by Mechanism of Action, 2015 26

AB Science SA-Recent Pipeline Updates, 2015 27

AB Science SA-Dormant Developmental Projects,2015 34

AB Science SA-Discontinued Pipeline Products, 2015 35

AB Science SA, Other Locations 36

List of Figures

AB Science SA-Pipeline by Top 10 Indication, 2015 7

AB Science SA-Pipeline by Stage of Development, 2015 9

AB Science SA-Monotherapy Products in Pipeline, 2015 10

AB Science SA-Pipeline by Top 10 Target, 2015 23

AB Science SA-Pipeline by Top 10 Route of Administration, 2015 24

AB Science SA-Pipeline by Top 10 Molecule Type, 2015 25

AB Science SA-Pipeline Products by Top 10 Mechanism of Action, 2015 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of AB Science SA; AB Science SA - Key Therapeutics; AB Science SA - Pipeline Overview and Promising Molecules; AB Science SA - News; AB Science SA - Latest Updates; AB Science SA - Pipeline; AB Science SA - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 102105
Site License
USD 3000 INR 204210
Corporate User License
USD 4500 INR 306315



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com